News and Comments

ARCA BIOPHARMA: A GENETICALLY TARGETED DRUG FOR ATRIAL FIBRILLATION IN HEART FAILURE PATIENTS

  Thursday, January 09, 2014

A Colorado-based biopharmaceutical company, ARCA Biopharma (ABIO) has a genetically-targeted drug, GencaroTM (bucindolol hydrochloride), for Atrial fibrillation (AF) in patients with heart failure (HF). The drug offers a personalized medicine approach for the treatment of AF in HF, treating only individuals with certain genetic characteristics. This approach enables the selection of individuals who would most probably respond to the drug through excluding the expected non-responders, thus reducing statistically failed trial outcome, in addition to decreasing clinical trial and healthcare costs.    More...


Recent Postings


Archive


Tags

Seattle Genetics (SGEN) Inovio (INO) Aimmune Therapeutics (AIMT) Roche (ROCHE) CompuGen (CGEN) ADVENTRIX (ANX) Merck (MRK) Intrexon (XON) Anacor (ANAC) Anadys (ANDS) Theravance (THRX) Bristol-Myers Squibb (BMY) Biocryst (BCRX) Dynavax (DVAX) Cytokinetics (CYTK) ImmunoGen (IMGN) Galena (GALE) Trastuzumab-DM1 Ziofpharm (ZIOP) Illumina (ILMN) Prosensa (RNA) C4 Therapeutics Sequenom (SQNM) IDERA (IDRA) Sanofi (SNA) Alnylam (ALNY) Ariad (ARIA) Agenus (AGEN Pluristem (PSTI) SERES THERAPEUTICS (MCRB) Velcade (bortezomib) Vertex (VRTX) Amgen (AMGN) Abbott Laboratories (ABT) Jazz Pharmaceuticals (JAZZ) Incyte (INCY) Exelixis (EXEL) ARCA (ABIO) Intercept (ICPT) NEKTAR (NKTR)) SYNTA (SNTA) Mirati Therapeutics (MRTX) Agenus (AGEN) Idenix (IDIX) JUNO (JUNO) BIOMARIN (BMRN) Valeant Pharmaceuticals International (VRX) ZALTRAP™ Array Pharmaceuticals (ARRY) Multiple Myeloma Tysabri Gilead (GILD) Sangamo (SGMO) GUARDIAN HEALTH NANTKWEST (NK) SUNESIS PHARMACEUTICALS (SNSS) VANDA (VNDA) Revlimid (lenolidamide) Herceptin Biogen Idec (BIIB) Xoma (XOMA) Micromet (MITI) Dendreon (DNDN) Telaprevir Rapamune HALOZYME (HALO) OSI (OSIP) KERYX (KERX) Sarepta (SRPT) ABBVIE (ABBV) Ridaforolimus Zerenex AERIE PHARMACEUTICALS Human Genome Sciences (HGSI) Auspex (ASPX) TOKAI (TKAOI) Endometrial Cancer Intermune (ITMN) Sanofi (SNY) ISIS (ISIS) Benlysta (belimumab) Sanofi-Aventis (SAN) Prolor Biotech (PBTH) GlaxoSmithKline (GSK) Roche (RHHBY) Elan (ELN) KITE (KITE) Onyx (ONXX) galapagos (GLPG) Regeneron (REGN) Genentech